The store will not work correctly when cookies are disabled.
2-Amino-4-(4-bromothenyloxy)-6-morpholino-5-nitropyrimidine
ID: ALA1683162
PubChem CID: 51351517
Max Phase: Preclinical
Molecular Formula: C13H14BrN5O4S
Molecular Weight: 416.26
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Nc1nc(OCc2cc(Br)cs2)c([N+](=O)[O-])c(N2CCOCC2)n1
Standard InChI: InChI=1S/C13H14BrN5O4S/c14-8-5-9(24-7-8)6-23-12-10(19(20)21)11(16-13(15)17-12)18-1-3-22-4-2-18/h5,7H,1-4,6H2,(H2,15,16,17)
Standard InChI Key: FREOARGPGHGJFR-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 26 0 0 0 0 0 0 0 0999 V2000
-4.2598 -1.1625 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-4.2609 -1.9898 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5461 -2.4027 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.8297 -1.9894 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8325 -1.1588 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5479 -0.7497 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.9757 -2.4018 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.1145 -2.4007 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.1175 -0.7423 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.1206 0.0827 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.4014 -1.1521 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.5504 0.0753 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.8371 0.4899 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8396 1.3149 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1702 1.8010 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4275 2.5849 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2525 2.5824 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5050 1.7970 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-1.9446 3.2538 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
-2.1176 -3.2259 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4065 -3.6372 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6903 -3.2271 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.6896 -2.4011 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4052 -1.9853 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6 12 1 0
6 1 1 0
12 13 1 0
1 2 2 0
13 14 1 0
14 15 2 0
2 7 1 0
3 4 2 0
4 8 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 14 1 0
4 5 1 0
16 19 1 0
8 20 1 0
2 3 1 0
9 10 2 0
9 11 1 0
5 9 1 0
5 6 2 0
8 24 1 0
20 21 1 0
21 22 1 0
22 23 1 0
23 24 1 0
M CHG 2 9 1 11 -1
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 416.26 | Molecular Weight (Monoisotopic): 414.9950 | AlogP: 2.21 | #Rotatable Bonds: 5 |
Polar Surface Area: 116.64 | Molecular Species: NEUTRAL | HBA: 9 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 9 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 4.73 | CX LogP: 3.17 | CX LogD: 3.17 |
Aromatic Rings: 2 | Heavy Atoms: 24 | QED Weighted: 0.58 | Np Likeness Score: -1.91 |
References
1. Lopez S, Margison GP, McElhinney RS, Cordeiro A, McMurry TB, Rozas I.. (2011) Towards more specific O6-methylguanine-DNA methyltransferase (MGMT) inactivators., 19 (5): [PMID:21320783] [10.1016/j.bmc.2011.01.038] |